IM Cannabis Corp (IMCC)
0.464
-0.01
(-1.49%)
USD |
NASDAQ |
Jun 18, 16:00
0.4583
-0.01
(-1.23%)
Pre-Market: 08:09
IM Cannabis Revenue (Quarterly): 8.944M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 8.944M |
| December 31, 2023 | 26.76M |
| September 30, 2023 | 28.39M |
| June 30, 2023 | 9.818M |
| March 31, 2023 | 9.260M |
| December 31, 2022 | 29.57M |
| September 30, 2022 | 30.54M |
| June 30, 2022 | 9.941M |
| March 31, 2022 | 10.26M |
| December 31, 2021 | 7.864M |
| September 30, 2021 | 6.383M |
| June 30, 2021 | 9.048M |
| March 31, 2021 | 6.917M |
| December 31, 2020 | 3.760M |
| September 30, 2020 | 4.422M |
| June 30, 2020 | 2.710M |
| March 31, 2020 | 0.9994M |
| July 31, 2019 | |
| April 30, 2019 | |
| January 31, 2019 | |
| July 31, 2018 | |
| April 30, 2018 | |
| January 31, 2018 | |
| October 31, 2017 | |
| July 31, 2017 |
| Date | Value |
|---|---|
| April 30, 2017 | |
| January 31, 2017 | |
| January 31, 2015 | |
| October 31, 2014 | |
| July 31, 2014 | |
| April 30, 2014 | |
| January 31, 2014 | |
| October 31, 2013 | |
| July 31, 2013 | |
| April 30, 2013 | |
| January 31, 2013 | |
| October 31, 2012 | |
| July 31, 2012 | |
| April 30, 2012 | |
| January 31, 2012 | |
| October 31, 2011 | |
| July 31, 2011 | |
| April 30, 2011 | |
| January 31, 2011 | |
| October 31, 2010 | |
| July 31, 2010 | |
| April 30, 2010 | |
| January 31, 2010 | |
| October 31, 2009 | |
| July 31, 2009 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.9994M
Minimum
Mar 2020
30.54M
Maximum
Sep 2022
12.09M
Average
9.048M
Median
Jun 2021
Revenue (Quarterly) Benchmarks
| Taro Pharmaceutical Industries Ltd | 164.94M |
| InspireMD Inc | 1.511M |
| BiomX Inc | -- |
| Alpha Tau Medical Ltd | -- |
| Pluri Inc | 0.071M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.464M |
| Total Expenses (Quarterly) | 13.12M |
| EPS Diluted (Quarterly) | -0.3114 |
| Enterprise Value | 13.70M |
| Gross Profit Margin (Quarterly) | 14.75% |
| Profit Margin (Quarterly) | -49.90% |
| Earnings Yield | -279.3% |
| Normalized Earnings Yield | -261.06 |